US Broker Ratings

Insulet Corporation (PODD) Stock Analysis: Unpacking a 14.20% Potential Upside

Investors eyeing the healthcare sector have good reason to consider Insulet Corporation (NASDAQ: PODD), a prominent player in the medical device industry with a market capitalization..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unpacking a Potential 17% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is drawing significant interest from investors, thanks to its robust pipeline and promising financial..

Teleflex Incorporated (TFX) Stock Analysis: A 12.62% Potential Upside Amidst Market Volatility

Teleflex Incorporated (NYSE: TFX), a prominent player in the medical instruments and supplies industry, has caught the attention of investors with its noteworthy potential upside of..

Sanofi (SNY) Investor Outlook: Analyzing the 22.84% Potential Upside and Dividend Yield

Sanofi (NYSE: SNY), a French pharmaceutical giant, is a key player in the healthcare sector, particularly in the drug manufacturing industry. With a substantial market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Promising Oncology Innovations with a 14.51% Upside Potential

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is capturing investor attention with its focused approach to combating RAS-addicted cancers. Based in Redwood City, California,..

Charles River Laboratories Inte (CRL): Investor Outlook Reveals 12.70% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) remains a noteworthy player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Novartis AG (NVS) Stock Analysis: Navigating a 3.12% Potential Upside with Robust Revenue Growth

For investors exploring opportunities in the healthcare sector, Novartis AG (NVS) presents a compelling case with its robust revenue growth and strategic focus on innovative therapies...

Hologic, Inc. (HOLX) Stock Analysis: Healthcare Innovator with Steady Growth and Modest Upside

Hologic, Inc. (NASDAQ: HOLX) stands as a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization..

Chemed Corp (CHE) Stock Analysis: A Healthcare Giant with 30% Upside Potential

Chemed Corp (NYSE: CHE) is an intriguing player in the healthcare sector, specifically positioned within the medical care facilities industry. With a market capitalization of $6.44..

Becton, Dickinson and Company (BDX) Stock Analysis: Growth Potential and Steady Dividend Yield

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and consistent financial performance...

Merck & Company, Inc. (MRK) Stock Analysis: Robust Growth and Dividend Strength in Healthcare Giant

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare industry, continues to capture the attention of investors with its solid market presence and promising..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Growth Potential with an 8.42% Upside

Investors keen on the healthcare sector might find Qiagen N.V. (QGEN) a compelling prospect. As a Netherlands-based leader in diagnostics and research, Qiagen offers innovative solutions..

The Ensign Group, Inc. (ENSG): Investor Outlook and 12% Upside Potential

Investors have their eyes on The Ensign Group, Inc. (NASDAQ: ENSG), with its impressive market presence in the healthcare sector and a remarkable potential upside of..

Genmab A/S (GMAB) Stock Analysis: Exploring a Promising 22% Upside Potential

In the ever-evolving landscape of biotechnology, Genmab A/S (NASDAQ: GMAB) stands as a significant player, particularly in the sector of antibody-based cancer treatments. With a market..

Alcon Inc. (ALC) Investor Outlook: Exploring a Promising 24% Upside Potential

Alcon Inc. (NYSE: ALC), a Swiss-based leader in the healthcare sector, particularly in medical instruments and supplies, stands as a beacon of innovation in the eye..

ICON plc (ICLR) Stock Analysis: Exploring a 25.30% Potential Upside in the Healthcare Sector

As investors navigate the ever-evolving landscape of the healthcare sector, ICON plc (NASDAQ: ICLR) emerges as a notable player with a compelling investment thesis. Headquartered in..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating the Healthcare Titan’s Growth Potential and Strategic Position

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, with a robust market capitalization of $14.76 billion. Headquartered in King..

Waystar Holding Corp. (WAY) Stock Analysis: Analyzing a Promising 37.54% Upside in the Healthcare Information Sector

Waystar Holding Corp. (WAY), a burgeoning force in the health information services industry, has captured investor attention with its potential upside of 37.54%, according to consensus..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 20% Upside Potential Amidst Healthcare Sector Dynamics

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. Operating numerous outpatient dialysis centers,..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking a 74.99% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing opportunity for investors looking to capitalize on the dynamic biotechnology sector. With a current market capitalization of $8.14..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds